(Q46891168)

26 December 2017

title

Lack of effect of growth hormone replacement therapy on CYP1A2 and xanthine oxidase activities in growth hormone-deficient children (English)

1 reference

26 December 2017

Hormone Replacement Therapy

main subject

1 reference

inferred from title

author name string

Esteban Mayayo-Sinués

1

1 reference

26 December 2017

Ana Fanlo

2

1 reference

26 December 2017

Blanca Sinués

3

1 reference

26 December 2017

Esteban Mayayo

4

1 reference

26 December 2017

Jose I Labarta

5

1 reference

26 December 2017

Angel García de Jalón

6

1 reference

26 December 2017

Angel Ferrández-Longás

7

1 reference

26 December 2017

publication date

12 January 2006

1 reference

26 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

26 December 2017

volume

62

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

123-127

1 reference

26 December 2017

Effect of human growth hormone on amobarbital metabolism in children.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0082-Y

Effect of allopurinol on caffeine disposition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0082-Y

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0082-Y

Free radicals in medicine. II. Involvement in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-005-0082-Y

Growth hormone replacement therapy induces codeine clearance

21 January 2018

1 reference

12 December 2020

A urinary metabolite ratio that reflects systemic caffeine clearance

1 reference

12 December 2020

Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat.

1 reference

12 December 2020

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

1 reference

12 December 2020

Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.

1 reference

12 December 2020

The many faces of human growth hormone

1 reference

12 December 2020

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

1 reference

12 December 2020

Xanthine oxidase catalyzed reductive cleavage of anthracycline antibiotics and free radical formation

1 reference

12 December 2020

Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P-450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test

1 reference

12 December 2020

Loss of fluorescence by anthracycline antibiotics: effects of xanthine oxidase and identification of the nonfluorescent metabolites

1 reference

12 December 2020

Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children

1 reference

12 December 2020

Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo[4,5-f]-quinoline by human adult and fetal livers

1 reference

12 December 2020

An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro. Studies with human and rat liver microsomes

1 reference

12 December 2020

Selective suppression of glutathione S-transferase activities in rat primary hepatocytes by growth hormone

1 reference

12 December 2020

Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.

1 reference

12 December 2020

Regulation of cytochrome P450 genes: molecular mechanisms

1 reference

12 December 2020

Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription

1 reference

12 December 2020

Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity

1 reference

12 December 2020

Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.

1 reference

12 December 2020

Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow

1 reference

12 December 2020

Effect of growth hormone on human drug metabolism: time course and substrate specificity

1 reference

12 December 2020

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity

1 reference

12 December 2020

Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat

1 reference

12 December 2020

Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system

1 reference

12 December 2020

Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver

1 reference

12 December 2020

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities

1 reference

12 December 2020

Effect of growth hormone on caffeine metabolism in hypophysectomized rats

1 reference

12 December 2020

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.

1 reference

12 December 2020

Caffeine as a metabolic probe: validation of its use for acetylator phenotyping

1 reference

12 December 2020

Single-dose kinetics of clomipramine: relationship to the sparteine and S-mephenytoin oxidation polymorphisms

1 reference

12 December 2020

Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements

1 reference

12 December 2020

10.1007/S00228-005-0082-Y

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017